Bristol, Tennessee — According to state and local economic development sources USAntibiotics plans to build out 360,000 square feet of new space in Bristol. The company plans to occupy the new space at 201 Industrial Drive in Bristol, on or about November 1, 2022. According to the company website USAntibiotics is the only authorized U.S. manufacturer of Amoxicillin and Amoxicillin Clavulanate, commonly known as Amoxil and Augmentin. Today, these medications account for more than 30 percent of all antibiotics prescribed each year. Approximately one in 12 Americans are prescribed Amoxicillin products on an annual basis. Given widespread use and demand, we play a vital role in enhancing national security by strengthening our country’s domestic medical supply chain with a high-quality, dependable alterative to offshore production of these life-saving medications. Our world-class antibiotic production facility is located on more than 40 acres in Bristol, Tennessee. Founded in 1978, we have a deep history and proven track record of doing what we do best producing quality, life-saving antibiotics and making them widely available for the benefit of all Americans. Our more than 360,000-square-foot operation boasts tremendous production power and is designated by the Department of Homeland Security as a critical manufacturing infrastructure facility.

To learn more about USAntibiotics, visit http://us-antibiotics.com/

Company Contact:
Shane Jackson, President
https://www.linkedin.com/in/shanejacksonculture/
423-274-3300

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved